Page last updated: 2024-08-17

levodopa and memantine

levodopa has been researched along with memantine in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (5.00)	18.7374
1990's	3 (15.00)	18.2507
2000's	5 (25.00)	29.6817
2010's	9 (45.00)	24.3611
2020's	2 (10.00)	2.80

Authors

Authors	Studies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE	1
Frey, HH; Voits, M	1
Danysz, W; Quack, G; Rogoz, Z; Skuza, G	1
Camicioli, R; Ganzini, L; Young, BK	1
Emre, M; Hanağasi, HA; Kaptanoglu, G; Sahin, HA	1
Archer, T; Danysz, W; Fredriksson, A; Quack, G	1
Kozhevnikova, ZhV; Krivonos, OV; Puzin, MN	1
Abdel Wahab, Z; El-Moursy, SA; Rashed, L; Shawky, HM	1
Di Rocco, A; Howard, J; Varanese, S	1
Litvinenko, IV; Mogil'naya, VI; Odinak, MM; Perstnev, SV	1
Aarsland, D; Engedal, K; Larsson, V; Londos, E; Minthon, L; Wattmo, C	1
Allorge, D; Blum, D; Bordet, R; Defebvre, L; Delval, A; Destée, A; Devos, D; Duhamel, A; Dujardin, K; Hossein-Foucher, C; Moreau, C; Petyt, G; Sablonnière, B; Schraen, S; Tiffreau, V	1
Fukushima, FB; Valle, AP; Vidal, EI; Villas Boas, PJ	1
Carta, M; Collu, M; Fidalgo, C; Gardoni, F; Morelli, M; Stancampiano, R; Tronci, E; Zianni, E	1
Wictorin, K; Widner, H	1
Leitinger, G; Maurer, C; Radulović, S; Sunkara, S	1
Dömötör, ZR; Farkas, N; Fehér, G; Gaál, V; Garami, A; Hegyi, P; Kanaan, R; Kiss, S; Lantos, K; Lujber, L; Szakács, Z; Varga, G	1

Reviews

3 review(s) available for levodopa and memantine

Article	Year
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment. Drugs & aging, 1997, Volume: 10, Issue:5 Topics: Aging; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Cholinergic Antagonists; Delirium; Dementia; Depression; Dopamine Agonists; Electroconvulsive Therapy; Humans; Levodopa; Memantine; Monoamine Oxidase Inhibitors; Psychoses, Substance-Induced; Risk Factors; Serotonin Antagonists	1997
Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders. International journal of molecular sciences, 2021, Nov-18, Volume: 22, Issue:22 Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Humans; Huntington Disease; Levodopa; Memantine; Microscopy, Electron; Multiple Sclerosis; Neuronal Plasticity; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Synapses; Synaptic Transmission; Tetrabenazine	2021
Efficacy of Treatments in Nonarteritic Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis. International journal of environmental research and public health, 2022, 02-26, Volume: 19, Issue:5 Topics: Adult; Humans; Levodopa; Memantine; Optic Neuropathy, Ischemic; Oxygen; Steroids; Visual Acuity	2022

Trials

4 trial(s) available for levodopa and memantine

Article	Year
Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia. Neuroscience and behavioral physiology, 2010, Volume: 40, Issue:2 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition; Cognition Disorders; Dementia; Disability Evaluation; Dyskinesias; Homocysteine; Humans; Levodopa; Memantine; Neuropsychological Tests; Nootropic Agents; Parkinson Disease; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome	2010
Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia. Dementia and geriatric cognitive disorders, 2011, Volume: 32, Issue:4 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Levodopa; Lewy Body Disease; Male; Memantine; Neuropsychological Tests; Parkinson Disease; Quality of Life; Treatment Outcome	2011
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study. Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:5 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Disability Evaluation; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Memantine; Middle Aged; Parkinson Disease; Pilot Projects; Sample Size	2013
Memantine and reduced time with dyskinesia in Parkinson's Disease. Acta neurologica Scandinavica, 2016, Volume: 133, Issue:5 Topics: Aged; Antiparkinson Agents; Cross-Over Studies; Double-Blind Method; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Humans; Levodopa; Male; Memantine; Middle Aged; Parkinson Disease	2016

Other Studies

13 other study(ies) available for levodopa and memantine

Article	Year
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects. Neuroendocrinology, 1975, Volume: 19, Issue:3 Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil	1975
Effect of psychotropic agents on a model of absence epilepsy in rats. Neuropharmacology, 1991, Volume: 30, Issue:6 Topics: Animals; Antidepressive Agents; Dextroamphetamine; Electroencephalography; Epilepsy; Female; Levodopa; Male; Memantine; Morphine; N-Methylaspartate; Parasympatholytics; Psychotropic Drugs; Rats; Rats, Inbred Strains	1991
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats. Journal of neural transmission. General section, 1994, Volume: 98, Issue:1 Topics: Amantadine; Animals; Bromocriptine; Dopamine; Drug Synergism; Levodopa; Male; Memantine; Motor Activity; N-Methylaspartate; Parkinson Disease; Rats; Rats, Wistar; Selegiline	1994
The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5 Topics: Adult; Antiparkinson Agents; Dopamine Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Humans; Levodopa; Male; Memantine; N-Methylaspartate; Parkinsonian Disorders; Treatment Outcome	2000
Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Dizocilpine Maleate; Dopamine Agents; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Levodopa; Male; Memantine; Mice; Mice, Inbred C57BL; Motor Activity; Parkinsonian Disorders; Recovery of Function	2001
[Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2007, Volume: 107, Issue:1 Topics: Antiparkinson Agents; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Humans; Levodopa; Male; Memantine; Middle Aged; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome	2007
The effect of memantine and levodopa/carbidopa on the responses of phrenic nerve-diaphragm preparations from aged rats. Medical science monitor : international medical journal of experimental and clinical research, 2009, Volume: 15, Issue:11 Topics: Aging; Animals; Carbidopa; Diaphragm; Electric Stimulation; Gallamine Triethiodide; Gene Expression Regulation; Levodopa; Male; Memantine; Muscle Contraction; Neostigmine; Neuromuscular Blockade; Phrenic Nerve; Protein Subunits; Rats; Receptors, Nicotinic; RNA, Messenger	2009
NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2010, Mar-15, Volume: 25, Issue:4 Topics: Aged; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Levodopa; Male; Memantine; N-Methylaspartate; Parkinson Disease	2010
Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia. Journal of the American Geriatrics Society, 2013, Volume: 61, Issue:1 Topics: Aged, 80 and over; Antiparkinson Agents; Dementia; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Memantine; Middle Aged; Parkinson Disease	2013
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. Neuroscience, 2014, Apr-18, Volume: 265 Topics: Amantadine; Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesias; Excitatory Amino Acid Antagonists; Levodopa; Male; Memantine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley	2014